Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

Repigmentation in vitiligo may come from melanocyte stem cells in the skin.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.

Most HIV patients in the study showed skin and mucous membrane issues, with oral thrush being the most common.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

The patient improved after antiviral treatment for a viral infection.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

A young woman with a rare skin cancer was diagnosed late because her symptoms were unusual for the disease.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Immortalized human dermal papilla cells were created that grow better and can still help form hair.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

An elderly man with skin amyloidosis and abnormal blood proteins was monitored without finding widespread disease after 18 months.

The PER3 rs772027021 SNP may cause mild skin pigmentation changes in a new subtype of dyschromatosis universalis hereditaria.

Ixekizumab has known and some unexpected side effects.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Non-itchy rashes can indicate serious diseases like lupus.

Somatostatin helps hair follicles suppress immune responses, which might aid in treating certain hair loss conditions.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.